Enrique Grande, Director of the Medical Oncology Department at Quirónsalud, and Adjunct Professor at The University of Texas MD Anderson Cancer Center, shared a post on LinkedIn:
“Yesterday I experienced one of those moments that give true meaning to everything we do every day.
Being able to contribute my small grain of sand to the training of patients with neuroendocrine tumors (NET) in the GEPAC Congress of the Spanish Group of Cancer Patients has been a real privilege.
I am deeply proud to have contributed to raising awareness of a rare disease, but much more prevalent than we sometimes think, and to be able to share with patients the enormous advances we have experienced in recent years in its diagnosis and treatment. Advances that are not just science: they are time, quality of life, and hope.
As director of the Cancer Program of Quirónsalud Madrid and as principal investigator of many of the studies that have allowed the approval of the treatments that we use today in daily practice, and of which we continue to research, to see patients up close, listen to their concerns and to be able to explain first-hand where we are going, it’s simply a reminder of why every effort is worth it.
Thank you from the bottom of my heart to GEPAC Congress of the Spanish Group of Cancer Patients for the invitation and, especially, to NET España for always being present and for the tireless work they do 365 days a year for their members and for all patients with NET. Your work is essential.
My thanks also go to the Spanish Neuroendocrine Tumour Group, of which I have the honour of being a member of the Board of Directors and which I proudly represent, and to Sociedad Española de Oncología Médica (SEOM), for their constant commitment to excellence in oncology.
I would also like to share that at Quirónsalud we are working on the development of a Cancer Program whose objective is clear: that all patients diagnosed with cancer or who want to be evaluated in the group can have priority access to the necessary tests for correct staging, to the molecular characterization of their tumor and, above all, to the evaluation by specialized tumor committees, with experts dedicated to each type of cancer. And we will do it hand in hand with patient associations, because only together does it make real sense.
Because, if we can’t always cure, we can always accompany.
And that accompaniment also heals.
Thank you to all of you who make it possible.”
More posts featuring Enrique Grande.